Strategic Planning
Roadmaps to Success
Strategy maps, popularized by Robert Kaplan and David Norton as part of the Balanced Scorecard paradigm, fit well into the biopharmaceutical imperative for creating and communicating durable therapeutic value.
The ParagonRx version of strategic maps demonstrates how value changes when appropriate use programs are implemented. This allows for both strategic and clinical validation of interventions to reduce risk and optimize use.
Do you need to demonstrate the potential value of a compound or justify a decision to senior management? ParagonRx can utilize our proprietary research and our ability to leverage pre-existing data about your compound or device to generate a realistic but powerful map.
By showing how risk mitigation or appropriate use can improve your upside forecast, we can reinforce the benefits of an appropriate use and risk management strategy for building or maintaining your brand.